Israel Radio reported Sunday morning that an Israeli company had developed a universal vaccine for all forms of flu – including bird and swine flu – and shares of Rehovot-based BiondVax trading on the Tel Aviv stock exchange went through the roof. But the ardor of investors was tempered somewhat when the company announced that it had not yet tested its vaccine on swine flu, nor had it conducted tests on pregnant women – one of the groups that is most susceptible to the disease, and for which developing a vaccine has been more difficult. Read Full Story
Archive for October, 2009
Israeli Super-Vaccine for Flu Reported
Friday, October 30th, 2009Latest Global Disaster Recovery research just released by Symantec
Friday, October 30th, 2009Symantec Corp have now released their annual Global Disaster Recovery Survey. Surveying 1,650 companies worldwide in June 2009, the target audience was CIO and CTO Executives within companies that had 5,000 or more staff.
The survey assesses many aspects of disaster recovery, including Cost of Downtime, Planned Budgets, Impacts of DR Testing and Virtualisation Trends.
The report can be found here: http://www.symantec.com/about/news/resources/press_kits/detail.jsp?pkid=disasterrecovery
BECOME A FAN and COME AND JOIN IN THE DISCUSSION
Wednesday, October 28th, 2009
 |
 |
 |
We are pleased to announce that OpsCentre’s Facebook Fan Page, Twitter and LinkedIn profiles are now up and running and we encourage you all to become a fan.
Facebook, Twitter and LinkedIn are great social media tools where all OpsCentre customers can come together and discuss latest trends in Business Continuity, Crisis Management, IT Disaster Recovery and more.
Keep an eye out on our pages on these sites for all the latest industry news and we welcome your participation on our OpsCentre’s Facebook Fan Page, Twitter and LinkedIn pages.
If you’re not signed up on these sites yet, it’s very easy to get started and become an OpsCentre fan. Simply follow the links below and log your email address with a password and you’re signed-up:
See you there.